Myopia Completed Phase 1 Trials for Bevacizumab (DB00112)

Also known as: Short-sighted / Short sightedness / Nearsighted

IndicationStatusPhase
DBCOND0009460 (Myopia)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00802126Intravitreal Bevacizumab and Low Fluence Photodynamic TherapyTreatment